Winslow Garrett bought DMRA
March 23, 2026 · Form 4 insider transaction
Winslow Garrett bought 250,000 shares of Damora Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
250,000
Price
$0.00
Total value
N/A
InsiderWinslow Garrett
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 23, 2026
Filing dateMarch 25, 2026
Shares owned after250,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase shares of common stock of the Issuer. This option will vest as to 25% on March 23, 2027 and in equal monthly installments thereafter through March 23, 2030, subject to the Reporting Person's continued service to the Issuer on each such vesting date.